Inici › Esquizofrènia › Illinois › Chicago
Assaigs clínics de Esquizofrènia a Chicago, IL
21 estudis de Esquizofrènia busquen participants en centres de Chicago i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
ReclutantVoluntaris sans benvinguts
- The University of Chicago, Chicago
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
ReclutantFase 1
- Uptown Research Institute, Chicago
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
ReclutantFase 3
- Local Institution - 0067, Chicago
- Pillar Clinical Research -Chicago, Chicago
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
ReclutantFase 3
- Neurocrine Clinical Site, Chicago
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
ReclutantFase 3
- Local Institution - 0175, Chicago
- EmVenio Research Center - Prime Healthcare, Chicago
A Study of Brenipatide in Adult Participants With Schizophrenia
ReclutantFase 2
- Re:Cognition Health - Chicago, Chicago
52-week Open Label Safety-Tolerability Study
ReclutantFase 3
- Pillar Clinical Research, Chicago
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
ReclutantFase 3
- Local Institution - 0122, Chicago
- EmVenio Research Center - Prime Healthcare, Chicago
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
ReclutantFase 1
- Uptown Research Institute, Chicago
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
ReclutantFase 2
- Clinical Site, Chicago
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
ReclutantFase 3
- Alkermes Investigator Site, Chicago
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
ReclutantFase 2
- Uptown Research Institute LLC, Chicago
- Pillar Clinical Research LLC, Chicago
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
ReclutantFase 3
- Pillar Clinical Research, Chicago
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
ReclutantFase 2
- Uptown Research Institute, Chicago
A Study to Evaluate the Effect of KarXT on Urological Safety
ReclutantFase 4
- Uptown Research Institute, Chicago
- Pillar Clinical Research -Chicago, Chicago
CLOZAPINE Response in Biotype-1
ReclutantFase 4
- University of Chicago, Chicago
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
ReclutantEstudi observacional
- University of Chicago Medical Center, Chicago
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
ReclutantFase 3
- Neurocrine Clinical Site, Chicago
Randomized Withdrawal Study in Patients With Schizophrenia
ReclutantFase 3
- Vanda Investigational Site, Chicago
Study of ALTO-101 in Patients With Schizophrenia
ReclutantFase 2
- Site 5056, Chicago
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
ReclutantFase 3Voluntaris sans benvinguts
- Reviva site, Chicago
Assaigs de Esquizofrènia en altres ciutats
- Atlanta, GA22 estudis
- Little Rock, AR19 estudis
- Hollywood, FL15 estudis
- Boston, MA14 estudis
- Houston, TX13 estudis
- San Diego, CA13 estudis
- New York City, NY13 estudis
- Hialeah, FL13 estudis
- Austin, TX13 estudis
- Garden Grove, CA12 estudis
- Germantown, MD11 estudis
- Miami, FL10 estudis
Altres estudis a Chicago
- Càncer de pulmó de cèl·lules no petites61 estudis
- Càncer de mama58 estudis
- Càncer (tots els tipus)51 estudis
- Càncer metastàtic45 estudis
- Càncer de pròstata45 estudis
- Obesitat41 estudis
- Càncer de pulmó41 estudis
- Càncer d'ovari36 estudis
- Ictus34 estudis
- Càncer colorrectal33 estudis
- Insuficiència cardíaca31 estudis
- Sobrepès28 estudis
De ClinicalTrials.gov, dades recuperades el 4 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.